| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 225 | 5.747 | 6.239 | 8.101 | 9.293 | 25.293 | 15.847 | 13.831 | 9.431 | 8.403 |
| Total Income - EUR | 225 | 5.747 | 6.239 | 8.360 | 9.293 | 30.450 | 15.915 | 13.832 | 9.431 | 8.404 |
| Total Expenses - EUR | 636 | 1.282 | 2.564 | 3.535 | 3.038 | 30.038 | 39.717 | 24.177 | 19.074 | 27.566 |
| Gross Profit/Loss - EUR | -411 | 4.465 | 3.675 | 4.825 | 6.256 | 412 | -23.802 | -10.345 | -9.642 | -19.163 |
| Net Profit/Loss - EUR | -418 | 4.293 | 3.515 | 4.574 | 5.977 | 114 | -23.961 | -10.483 | -9.642 | -19.163 |
| Employees | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 1 | 1 | 0 |
Check the financial reports for the company - Iaspis Therapy S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 145 | 248 | 167 | 88 | 12 | 6.493 | 33.988 | 27.197 | 20.239 | 14.941 |
| Current Assets | 47 | 4.289 | 8.014 | 9.911 | 10.234 | 5.184 | 2.853 | 3.255 | 6.948 | 9.851 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 338 | 5 | 0 | 0 | 5.056 | 1.831 | 2.785 | 3.272 | 5.441 |
| Cash | 47 | 3.951 | 8.009 | 9.911 | 10.234 | 128 | 1.021 | 470 | 3.676 | 4.411 |
| Shareholders Funds | -220 | 4.075 | 7.522 | 9.696 | 10.161 | 6.027 | -18.068 | -28.607 | -38.163 | -57.112 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 412 | 462 | 396 | 303 | 85 | 5.650 | 54.909 | 59.059 | 65.349 | 81.905 |
| Income in Advance | 0 | 268 | 264 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Iaspis Therapy S.r.l.